13F-HR/A filed by Eversept Partners, LP
Eversept Partners, LP filed this 13F-HR/A for the quarter ended 2018-03-31, filed 2023-11-08, with 57 holding rows worth $215,306,105.
- Accession
- 0001697013-23-000007
- Filer
- CIK 1697013
- Filed
- 2023-11-08
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2018
A holdings report, amendment of type restatement, 57 entries on the cover page, a total value of $215,306,105 stated on the cover page (in dollars after the unit check, H1), rows summing to $215,306,105 with VALUE read as dollars as filed, 13F file number 028-18369. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| QUALITY CARE PPTYS INC | 747545101 | COM | 1,030,661 | $20,025,743 | dollars as filed | |
| SPY | 78462F103 | SHS | 60,000 | $15,789,000 | dollars as filed | put |
| R1 RCM INC | 749397105 | COM | 1,909,887 | $13,636,593 | dollars as filed | |
| RADIUS HEALTH INC | 750469207 | COM NEW | 333,738 | $11,994,544 | dollars as filed | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 210,778 | $11,434,707 | dollars as filed | |
| ABLYNX NV | 00372Y105 | SPONSORED ADR | 181,891 | $9,923,973 | dollars as filed | |
| AVEXIS INC | 05366U100 | COM | 78,201 | $9,664,080 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 78,893 | $9,396,156 | dollars as filed | |
| GLAXOSMITHKLINE PLC-ADR | 37733W105 | SPONSORED ADR | 226,584 | $8,948,163 | dollars as filed | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 220,788 | $8,721,126 | dollars as filed | |
| ENSIGN GROUP INC | 29358P101 | COM | 325,897 | $8,585,124 | dollars as filed | |
| ZOGENIX INC. | 98978L204 | Common Stock | 204,546 | $8,192,067 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 44,822 | $7,305,090 | dollars as filed | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 357,727 | $5,838,105 | dollars as filed | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 137,972 | $5,529,918 | dollars as filed | |
| NEVRO CORP | 64157F103 | COM | 60,850 | $5,273,870 | dollars as filed | |
| TELIGENT INC NEW | 87960W104 | COM | 1,550,383 | $5,209,287 | dollars as filed | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 24,000 | $3,865,680 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 46,000 | $3,729,220 | dollars as filed | |
| TESARO INC | 881569107 | COM | 51,523 | $2,944,024 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 35,784 | $2,878,465 | dollars as filed | |
| Abbott Laboratories | 002824100 | COM | 47,900 | $2,870,168 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 150,000 | $2,130,000 | dollars as filed | |
| ABIOMED INC | 003654100 | COM | 7,094 | $2,064,283 | dollars as filed | |
| MYOKARDIA INC | 62857M105 | COM | 42,000 | $2,049,600 | dollars as filed | |
| INVACARE CORP | 461203101 | COMMON STOCK | 99,902 | $1,738,295 | dollars as filed | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 85,090 | $1,705,204 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 24,054 | $1,573,132 | dollars as filed | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 22,924 | $1,559,978 | dollars as filed | |
| CARETRUST REIT INC COM | 14174T107 | REIT | 108,264 | $1,472,932 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 6,000 | $1,318,200 | dollars as filed | |
| MEDICINES CO | 584688105 | COM | 39,317 | $1,295,102 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 65,000 | $1,098,500 | dollars as filed | |
| HAEMONETICS CORP MASS COM | 405024100 | Stock | 14,646 | $1,071,501 | dollars as filed | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 10,000 | $1,068,700 | dollars as filed | |
| EHEALTH INC | 28238P109 | COM | 74,546 | $1,066,753 | dollars as filed | |
| EPIZYME INC | 29428V104 | COM | 57,449 | $1,019,720 | dollars as filed | |
| MAGELLAN HEALTH SERVICES INC | 559079207 | COM NEW | 9,282 | $994,102 | dollars as filed | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 17,800 | $859,740 | dollars as filed | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 20,900 | $825,550 | dollars as filed | call |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 3,000 | $753,390 | dollars as filed | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 250,000 | $752,500 | dollars as filed | |
| IRADIMED CORP | 46266A109 | COMMON STOCK | 51,059 | $735,250 | dollars as filed | |
| AFFIMED N V | N01045108 | COM | 386,862 | $715,695 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 148,959 | $710,534 | dollars as filed | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 30,000 | $595,500 | dollars as filed | |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 117,495 | $587,475 | dollars as filed | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 18,029 | $587,205 | dollars as filed | |
| MELINTA THERAPEUTICS INC | 58549G100 | COM | 76,837 | $568,594 | dollars as filed | |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 107,500 | $551,475 | dollars as filed | |
| AQUINOX PHARMACEUTICALS INC | 03842B101 | COM | 31,987 | $450,377 | dollars as filed | |
| OPHTHOTECH CORP | 683745103 | COM | 149,100 | $408,534 | dollars as filed | |
| ENVISION HEALTHCARE CORP | 29414D100 | COM | 9,520 | $365,854 | dollars as filed | |
| MIMEDX GROUP INC | 602496101 | COM | 48,000 | $334,560 | dollars as filed | call |
| SEASPINE HLDGS CORP | 81255T108 | COM | 30,899 | $313,316 | dollars as filed | |
| DERMIRA INC | 24983L104 | COM | 20,018 | $159,944 | dollars as filed | |
| QUOTIENT LTD | G73268107 | SHS | 10,511 | $49,507 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001697013-18-000004 | superseded | 2018-05-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001697013-23-000007 | this filing | 2023-11-08 | acceptance time not in the bulk data set |